Literature DB >> 26424568

Human endogenous retrovirus-K contributes to motor neuron disease.

Wenxue Li1, Myoung-Hwa Lee1, Lisa Henderson1, Richa Tyagi1, Muzna Bachani2, Joseph Steiner2, Emilie Campanac3, Dax A Hoffman3, Gloria von Geldern1, Kory Johnson4, Dragan Maric1, H Douglas Morris5, Margaret Lentz6, Katherine Pak7, Andrew Mammen7, Lyle Ostrow8, Jeffrey Rothstein8, Avindra Nath9.   

Abstract

The role of human endogenous retroviruses (HERVs) in disease pathogenesis is unclear. We show that HERV-K is activated in a subpopulation of patients with sporadic amyotrophic lateral sclerosis (ALS) and that its envelope (env) protein may contribute to neurodegeneration. The virus was expressed in cortical and spinal neurons of ALS patients, but not in neurons from control healthy individuals. Expression of HERV-K or its env protein in human neurons caused retraction and beading of neurites. Transgenic animals expressing the env gene developed progressive motor dysfunction accompanied by selective loss of volume of the motor cortex, decreased synaptic activity in pyramidal neurons, dendritic spine abnormalities, nucleolar dysfunction, and DNA damage. Injury to anterior horn cells in the spinal cord was manifested by muscle atrophy and pathological changes consistent with nerve fiber denervation and reinnervation. Expression of HERV-K was regulated by TAR (trans-activation responsive) DNA binding protein 43, which binds to the long terminal repeat region of the virus. Thus, HERV-K expression within neurons of patients with ALS may contribute to neurodegeneration and disease pathogenesis.
Copyright © 2015, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26424568      PMCID: PMC6344353          DOI: 10.1126/scitranslmed.aac8201

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  176 in total

1.  Rebound from Inhibition: Self-Correction against Neurodegeneration?

Authors:  Shobhana Sivaramakrishnan; William P Lynch
Journal:  J Clin Cell Immunol       Date:  2017-03-13

2.  Motor neuron disease: Human endogenous retrovirus-K activation is implicated in amyotrophic lateral sclerosis.

Authors:  Heather Wood
Journal:  Nat Rev Neurol       Date:  2015-10-20       Impact factor: 42.937

Review 3.  The Retrotransposon storm and the dangers of a Collyer's genome.

Authors:  Josh Dubnau
Journal:  Curr Opin Genet Dev       Date:  2018-05-08       Impact factor: 5.578

4.  Dendritic Spine Density and Dynamics of Layer 5 Pyramidal Neurons of the Primary Motor Cortex Are Elevated With Aging.

Authors:  A M Davidson; H Mejía-Gómez; M Jacobowitz; R Mostany
Journal:  Cereb Cortex       Date:  2020-03-21       Impact factor: 5.357

5.  Medicine's movable feast: What jumping genes can teach us about treating disease.

Authors:  Roxanne Khamsi
Journal:  Nat Med       Date:  2017-07-11       Impact factor: 53.440

Review 6.  Silencing of endogenous retroviruses by heterochromatin.

Authors:  Sophia Groh; Gunnar Schotta
Journal:  Cell Mol Life Sci       Date:  2017-02-03       Impact factor: 9.261

Review 7.  Keeping it in check: chronic viral infection and antiviral immunity in the brain.

Authors:  Katelyn D Miller; Matthias J Schnell; Glenn F Rall
Journal:  Nat Rev Neurosci       Date:  2016-11-04       Impact factor: 34.870

8.  HERV-W env regulates calcium influx via activating TRPC3 channel together with depressing DISC1 in human neuroblastoma cells.

Authors:  Yatang Chen; Qiujin Yan; Ping Zhou; Shan Li; Fan Zhu
Journal:  J Neurovirol       Date:  2018-11-05       Impact factor: 2.643

Review 9.  Infectious agents and amyotrophic lateral sclerosis: another piece of the puzzle of motor neuron degeneration.

Authors:  David Castanedo-Vazquez; Pilar Bosque-Varela; Arancha Sainz-Pelayo; Javier Riancho
Journal:  J Neurol       Date:  2018-05-29       Impact factor: 4.849

10.  HIV-associated motor neuron disease: HERV-K activation and response to antiretroviral therapy.

Authors:  Lauren N Bowen; Richa Tyagi; Wenxue Li; Tariq Alfahad; Bryan Smith; Mary Wright; Elyse J Singer; Avindra Nath
Journal:  Neurology       Date:  2016-09-24       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.